Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic inflammation

Overview of attention for article published in BMC Pulmonary Medicine, February 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

policy: 1 policy source
twitter: 8 X users

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 205 Dimensions

Readers on

mendeley: 155 Mendeley

Summary Policy documents X Wikipedia Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

Benralizumab for treating severe eosinophilic asthma : Appraisal consultation 1 committee papers

Cited by National Institute for Health and Care Excellence on 03 May 2018

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Mepolizumab for treating severe refractory eosinophilic asthma: Committee papers

Cited by National Institute for Health and Care Excellence on 04 Apr 2016

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.